Kowalska Anna, Jamrozik Zygmunt, Kwieciński Hubert
Institute of Human Genetics, Polish Academy of Sciences, Poznań, Poland.
Folia Neuropathol. 2004;42(2):119-23.
Progressive supranuclear palsy (PSP), also known as Steele-Richardson-Olszewski syndrome, is a rare form of parkinsonism characterised by abundant tau pathology. Only a few familial cases have been reported, therefore PSP can be considered as a sporadic tauopathy. Recent case-control studies of patients with sporadic PSP suggest that PSP has a recessive pattern of inheritance. Strong genetic evidences for the involvement of the tau gene variability in the pathogenesis of PSP have been demonstrated in several Caucasian populations. We review the most important DNA polymorphisms (e.g.: A0 polymorphism and H1 haplotype) contributing to the risk of PSP. Moreover, we discuss how these DNA polymorphisms may influence the exon 10 splicing, and thus the proportion of 4R/3R tau isoforms, leading to a class II tau pathology in PSP patients.
进行性核上性麻痹(PSP),也称为斯蒂尔-理查森-奥尔谢夫斯基综合征,是一种罕见的帕金森综合征形式,其特征是存在大量tau蛋白病变。仅报告了少数家族性病例,因此PSP可被视为散发性tau蛋白病。最近对散发性PSP患者的病例对照研究表明,PSP具有隐性遗传模式。在几个白种人群体中已证实tau基因变异参与PSP发病机制的有力遗传证据。我们综述了导致PSP风险的最重要的DNA多态性(例如:A0多态性和H1单倍型)。此外,我们讨论了这些DNA多态性如何影响外显子10剪接,进而影响4R/3R tau异构体的比例,导致PSP患者出现II类tau蛋白病变。